| 000 | 01327 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513032140.0 | ||
| 264 | 0 | _c19951108 | |
| 008 | 199511s 0 0 eng d | ||
| 022 | _a0008-5472 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHerman, J G | |
| 245 | 0 | 0 |
_aInactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. _h[electronic resource] |
| 260 |
_bCancer research _cOct 1995 |
||
| 300 |
_a4525-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aCarrier Proteins _xgenetics |
| 650 | 0 | 4 | _aCpG Islands |
| 650 | 0 | 4 | _aCyclin-Dependent Kinase Inhibitor p16 |
| 650 | 0 | 4 |
_aDNA, Neoplasm _xgenetics |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aGenes, Tumor Suppressor |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMethylation |
| 650 | 0 | 4 | _aPromoter Regions, Genetic |
| 650 | 0 | 4 |
_aRNA, Neoplasm _xgenetics |
| 650 | 0 | 4 | _aRestriction Mapping |
| 650 | 0 | 4 | _aSequence Deletion |
| 700 | 1 | _aMerlo, A | |
| 700 | 1 | _aMao, L | |
| 700 | 1 | _aLapidus, R G | |
| 700 | 1 | _aIssa, J P | |
| 700 | 1 | _aDavidson, N E | |
| 700 | 1 | _aSidransky, D | |
| 700 | 1 | _aBaylin, S B | |
| 773 | 0 |
_tCancer research _gvol. 55 _gno. 20 _gp. 4525-30 |
|
| 999 |
_c7553077 _d7553077 |
||